Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
225 USD | +1.55% | -1.76% | -13.04% |
Jul. 16 | Biogen Needs Revenue-Generating Assets to Complete Turnaround, Wedbush Says | MT |
Jul. 16 | Redburn Atlantic Adjusts Price Target on Biogen to $230 From $235, Maintains Neutral Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.04% | 32.26B | |
+7.40% | 101B | |
+8.42% | 42.18B | |
+80.80% | 29.79B | |
-10.92% | 16.06B | |
+1.93% | 14.45B | |
-6.77% | 12.01B | |
+177.16% | 10.71B | |
+4.12% | 8.89B | |
-56.13% | 8.83B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Ewopharma Partners with Biogen to Commercialize BENEPALI® and FLIXABI® in Central Eastern Europe